title: Plasma homocysteine in subjects with familial combined hyperlipidemia.
abstract: Familial combined hyperlipidemia (FCH) is characterised by hypercholesterolemia and/or hypertriglyceridemia and associated with an increased risk of cardiovascular disease (CVD). The plasma lipid and lipoprotein levels in subjects with FCH are relatively moderately elevated and do not fully explain the increased risk of CVD. Hyperhomocysteinemia is a disorder of methionine metabolism and also a well-known independent risk factor for CVD. We investigated whether subjects with FCH have higher plasma homocysteine concentrations than controls, and whether homocysteine contributes to the increased risk of CVD in FCH. Furthermore we evaluated whether parameters of lipid and lipoprotein metabolism and/or insulin resistance are associated with the homocysteine level. In total 667 subjects, including 161 subjects with FCH, 109 spouses who referenced as control group and 397 normolipidemic relatives were studied. FCH was defined by the presence of plasma total cholesterol and/or triglyceride levels above the 90th percentile adjusted for age and gender. The mean homocysteine concentration of the FCH group did not significantly differ from the control group. The risk for CVD due to hyperhomocysteinemia in subjects with FCH was not higher than in subjects without FCH. No associations were observed between plasma homocysteine concentration and plasma lipid and lipoprotein levels, including small dense low density lipoprotein, nor between homocysteine concentration and insulin resistance.
authors.affiliation: Department of Medicine, Division of General Internal Medicine, 541, University Medical Center Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. m.veerkamp@aig.umcn.nl
authors.forename: M J
authors.initials: MJ
authors.lastname: Veerkamp
authors.forename: J
authors.initials: J
authors.lastname: de Graaf
authors.forename: M
authors.initials: M
authors.lastname: den Heijer
authors.forename: H J
authors.initials: HJ
authors.lastname: Blom
authors.forename: A F H
authors.initials: AF
authors.lastname: Stalenhoef
mesh_terms: D000328:Adult; D001055:Apolipoproteins B / Q000097:blood*; D001794:Blood Pressure; D015992:Body Mass Index; D002784:Cholesterol / Q000097:blood*; D003327:Coronary Disease / Q000097:blood / Q000209:etiology; D005260:Female; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D006950:Hyperlipidemia, Familial Combined / Q000097:blood* / Q000150:complications; D007333:Insulin Resistance; D008297:Male; D008875:Middle Aged; D012044:Regression Analysis; D012307:Risk Factors
chemical_list: D001055:Apolipoproteins B; D006710:Homocysteine; D002784:Cholesterol